REVOLUTION MEDICINES INC (RVMD)

US76155X1000 - Common Stock

31.72  +1.72 (+5.73%)

After market: 31.72 0 (0%)

Buy % Consensus

88

ChartMill assigns a Buy % Consensus number of 88% to RVMD. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 39.22. This target is 23.66% above the current price.
RVMD was analyzed by 18 analysts. The buy percentage consensus is at 88. So analysts seem to be very confident about RVMD.
In the previous month the buy percentage consensus was at a similar level.
RVMD was analyzed by 18 analysts, which is quite many. So the average rating should be quite meaningful.

Price Target & Forecast

Price Low Median Mean High 31.7234.3438.7639.2246.20 - 8.26% 22.19% 23.66% 45.65%
Up and Down Grades
Date Firm Action Rating
2024-03-11 Piper Sandler Initiate Overweight
2024-03-08 Morgan Stanley Maintains Equal-Weight -> Equal-Weight
2024-03-08 HC Wainwright & Co. Maintains Buy -> Buy
2024-02-27 Wedbush Maintains Outperform -> Outperform
2024-01-16 Raymond James Maintains Outperform -> Outperform
2024-01-05 B of A Securities Upgrade Neutral -> Buy
2023-12-20 UBS Initiate Buy
2023-11-16 Raymond James Initiate Outperform
2023-11-13 HC Wainwright & Co. Maintains Buy -> Buy
2023-11-07 Needham Reiterate Buy -> Buy
2023-11-07 JP Morgan Maintains Overweight -> Overweight
2023-10-26 HC Wainwright & Co. Reiterate Buy -> Buy
2023-10-23 Needham Maintains Buy -> Buy
2023-10-23 Oppenheimer Maintains Outperform -> Outperform
2023-10-12 Needham Reiterate Buy -> Buy
2023-09-21 Stifel Maintains Buy -> Buy
2023-08-09 Needham Maintains Buy -> Buy
2023-08-02 Needham Maintains Buy -> Buy
2023-08-02 Oppenheimer Maintains Outperform -> Outperform
2023-08-02 HC Wainwright & Co. Reiterate Buy -> Buy
2023-05-09 Needham Maintains Buy
2023-05-09 Oppenheimer Reiterate Outperform
2023-04-12 HC Wainwright & Co. Reiterate Buy
2023-03-01 Goldman Sachs Maintains Neutral
2023-02-28 Guggenheim Reiterate Buy
2023-02-28 Needham Maintains Buy
2023-02-28 Oppenheimer Maintains Outperform
2023-02-28 JP Morgan Upgrade Neutral -> Overweight
2022-12-14 Needham Initiate Buy
2022-12-08 HC Wainwright & Co. Maintains Buy